Researchers in Nova Scotia led by Dalhousie University's Christopher McMaster have developed new treatments for superbugs — ...

Could the secret to reducing childhood allergies be as simple as growing up with a pet or living on a farm? A fascinating ...

By slicing and dicing a dataset from 277 million patients at 1,591 hospitals, Epic publishes findings more quickly than ...

The panelist discusses how antibiotics are paradoxically both the primary treatment for Clostridioides difficile infections ...

The AHA 2025 Health Care Workforce Scan is based on the latest reports, studies and other data sources and offers valuable insights into the workforce landscape, as well as practical guidance from ...

Testing for C. difficile is indicated in patients with diarrhea, especially after antibiotic use or healthcare exposure.

Moderna’s top executives have sought to reassure investors they will be able to carry out the comeback plans announced in ...

While the idea of receiving a stool transplant may sound unappealing its benefits are substantial especially for those suffering from difficult-to-treat gastrointestinal issues Read ahead to know!

MELBOURNE, Australia, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Immuron Limited (ASX: IMC; NASDAQ: IMRN) is pleased to advise our Chief Executive Officer, Steven Lydeamore presented early this morning at the ...

Researchers shrink gastrointestinal tumors in mice using a yeast probiotic to deliver immunotherapy to the gut, offering a potentially novel strategy to target hard-to-reach gut cancers.

Beyond rare diseases and oncology, Recursion’s pipeline includes two candidates. One is REC-3964, an oral, non-antibiotic small molecule designed to treat Clostridioides difficile (C. diff) by ...